Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
Authors
Keywords
-
Journal
Acta Neuropathologica Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-18
DOI
10.1186/s40478-021-01196-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of CB2R with AM1241 ameliorates neurodegeneration via the Xist/miR‐133b‐3p/Pitx3 axis
- (2020) Xiaolie He et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors
- (2020) Si-yu Ren et al. ACTA PHARMACOLOGICA SINICA
- Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
- (2020) Francesco Panza et al. Nature Reviews Neurology
- Cannabinoids and Cannabinoid Receptors: The Story so Far
- (2020) Fred Shahbazi et al. iScience
- Progress in Brain Cannabinoid CB2 Receptor Research: From Genes to Behavior
- (2019) Chloe J. Jordan et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- A walk through tau therapeutic strategies
- (2019) Santosh Jadhav et al. Acta Neuropathologica Communications
- CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: Implications in tauopathies
- (2019) Sara Castro-Sánchez et al. Redox Biology
- Cannabinoid CB2 Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial Cells
- (2019) M. Galán-Ganga et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Cannabinoids and the expanded endocannabinoid system in neurological disorders
- (2019) Luigia Cristino et al. Nature Reviews Neurology
- Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation
- (2018) Janos Paloczi et al. ANTIOXIDANTS & REDOX SIGNALING
- Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis
- (2018) Francisco Espejo-Porras et al. BRITISH JOURNAL OF PHARMACOLOGY
- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
- (2018) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Biphasic effects of THC in memory and cognition
- (2018) Edward J. Calabrese et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer’s Disease-Like Pathology
- (2018) Anne-Caroline Schmöle et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease
- (2018) Alicia López et al. Journal of Neuroinflammation
- Tau-targeting therapies for Alzheimer disease
- (2018) Erin E. Congdon et al. Nature Reviews Neurology
- Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy
- (2018) Antonio Cuadrado et al. Redox Biology
- Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
- (2018) Cyril Laurent et al. Biomedical Journal
- JNK Plays a Key Role in Tau Hyperphosphorylation in Alzheimer's Disease Models
- (2018) Cristina Ploia et al. JOURNAL OF ALZHEIMERS DISEASE
- CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
- (2018) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease
- (2018) Gaurav Bedse et al. JOURNAL OF ALZHEIMERS DISEASE
- NMDA receptors and BDNF are necessary for discrimination of overlapping spatial and non-spatial memories in perirhinal cortex and hippocampus
- (2018) Magdalena Miranda et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Endocannabinoid system in neurodegenerative disorders
- (2017) Balapal S. Basavarajappa et al. JOURNAL OF NEUROCHEMISTRY
- Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer’s Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway
- (2017) Lin Wang et al. MOLECULAR NEUROBIOLOGY
- Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo
- (2017) Daniel J. Apicco et al. NATURE NEUROSCIENCE
- Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus
- (2017) Yong Li et al. NEUROSCIENCE
- Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
- (2017) Mauro Maccarrone et al. Expert Review of Clinical Pharmacology
- Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
- (2017) Tommaso Cassano et al. Frontiers in Neuroscience
- Human TAUP301L overexpression results in TAU hyperphosphorylation without neurofibrillary tangles in adult zebrafish brain
- (2017) Mehmet I. Cosacak et al. Scientific Reports
- The CB2 receptor and its role as a regulator of inflammation
- (2016) Caroline Turcotte et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine
- (2016) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism
- (2016) Judith Alferink et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Central Move for CB2 Receptors
- (2016) Salma A. Quraishi et al. NEURON
- Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
- (2016) A. Vanessa Stempel et al. NEURON
- Type-2 cannabinoid receptors in neurodegeneration
- (2016) Tiziana Bisogno et al. PHARMACOLOGICAL RESEARCH
- Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology
- (2016) Nicole Maphis et al. Alzheimers Research & Therapy
- Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist
- (2016) Wei Bu et al. Frontiers in Neuroscience
- Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
- (2016) Gemma Navarro et al. Frontiers in Neuroscience
- CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
- (2016) Ester Aso et al. Frontiers in Neuroscience
- Endocannabinoids drive the acquisition of an alternative phenotype in microglia
- (2015) M. Mecha et al. BRAIN BEHAVIOR AND IMMUNITY
- Age-related changes in the endocannabinoid system in the mouse hippocampus
- (2015) Anastasia Piyanova et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
- (2015) Javier Fernández-Ruiz et al. Neurotherapeutics
- Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
- (2014) Salvador Sierra et al. Brain Structure & Function
- Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis
- (2013) Valerio Chiurchiù et al. ANNALS OF NEUROLOGY
- Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis
- (2013) Isabel Lastres-Becker et al. BRAIN
- Changes in CB1and CB2receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
- (2013) Carmen Rodríguez-Cueto et al. BRITISH JOURNAL OF PHARMACOLOGY
- Object recognition test in mice
- (2013) Marianne Leger et al. Nature Protocols
- Characteristics of Tau Oligomers
- (2013) Yan Ren et al. Frontiers in Neurology
- The dual neuroprotective-neurotoxic profile of cannabinoid drugs
- (2011) Yosef Sarne et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus
- (2011) Anushka V. Goonawardena et al. NEUROPHARMACOLOGY
- CB2: a cannabinoid receptor with an identity crisis
- (2010) Brady K Atwood et al. BRITISH JOURNAL OF PHARMACOLOGY
- New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
- (2010) Wei Deng et al. NATURE REVIEWS NEUROSCIENCE
- The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas
- (2010) Eiron Cudaback et al. PLoS One
- Cannabinoid CB2receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
- (2009) Onintza Sagredo et al. GLIA
- Knock-out and transgenic mouse models of tauopathies
- (2007) Franziska Denk et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now